QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPSChina Warehouse
What is BPC-157 + TB-500 + KPV Blend?
This triple-peptide blend combines BPC-157 (Body Protection Compound), TB-500 Fragment (active actin-binding domain of Thymosin Beta-4), and KPV (Lys-Pro-Val, active C-terminal fragment of α-MSH). Each component targets distinct healing pathways: BPC-157 modulates growth factor signalling, angiogenesis, and gut mucosal repair; TB-500 Fragment drives cell migration, actin polymerisation, and anti-inflammatory cytokine suppression; KPV provides direct anti-inflammatory and gut epithelial barrier protection via MC1R/NF-κB pathways. Research use only.
Research Applications
Synergistic Tissue Repair
BPC-157 + TB-500 combined effect on wound closure, fibroblast migration, and angiogenesis
Gut Mucosal Healing
BPC-157 and KPV complementary mechanisms in intestinal epithelial barrier restoration, IBD models
Anti-Inflammatory Signalling
Triple-pathway NF-κB suppression: BPC-157 (VEGFR2), TB-500 (actin/cytokine), KPV (MC1R)
Angiogenesis & Vascularisation
BPC-157 VEGF upregulation combined with TB-500 endothelial migration
Multi-Target Recovery Research
Combined musculoskeletal, intestinal, and systemic recovery pathway modelling
Quick Specs
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 137525-51-0 / 107761-42-2 / 69661-79-6 |
| Molecular Formula | BPC-157 C₆₂H₉₈N₁₆O₂₂ + TB-500 Fragment C₂₁H₃₈N₈O₇S + KPV C₁₅H₂₈N₄O₅ |
| Identity | MS molecular weight confirmed — every batch |
| Peptide Type | Triple-Peptide Recovery & Gut-Healing Blend |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (4 weeks) |
| Shelf Life | 24 months (unopened) |

